Additional file 2: of A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

Additional file 1: of Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant

Sibylle Winterhalter (3575630)
Gerrit vom Brocke (3575633)
Daniel Pilger (270591)
Annabelle Eckert (3575621)
Juliane Schlomberg (651164)
Anne RĂźbsam (3575642)
Matthias Klamann (3575636)
Enken Gundlach (847310)
Tina Dietrich-Ntoukas (3575639)
Antonia Joussen (3575627)

October 2016

a-c) waterfall plots of the ETDRS letter change 1 to 5Â months after DEX implantation compared to ba...

Additional file 1: of One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy

Hsin-Yu Weng (6701684)
Tzu-Lun Huang (6701687)
Pei-Yao Chang (6701690)
Jia-Kang Wang (6701693)

May 2019

The raw data of the study. âOne-year outcome of combination therapy with intravitreal aflibercept ...

Additional file 1: of Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis

Kristina Lundwall (5791676)
Stefan Jacobson (5791679)
Gun Jรถrneskog (5791685)
Jonas Spaak (4338955)

September 2018

(SearchCochrane): Data search Cochrane; Data search strategy for Cochrane reviews and Cochrane trial...

Additional file 2: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S1. Baseline values for BCVA, CRT and SFCT. Differences in BCVA, CRT and SFCT between endpoint...

Additional file 2: of Cost-effectiveness of fluocinolone acetonide implant (ILUVIENÂŽ) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Michal Pochopien (6192851)
Annette Beiderbeck (6192857)
Phil McEwan (688067)
Richard Zur (6192860)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)

January 2019

NMA SLR supplement Supplementary materials explaining the methods used in the systematic literature ...

Additional file 6: Table S6. of Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

F. Ziemssen (3682612)
N. Feltgen (3682609)
FG. Holz (3682621)
R. Guthoff (3682618)
A. Ringwald (3682606)
T. Bertelmann (3682624)
A. Wiedon (3682615)
C. Korb (3682603)

January 2017

Table of confidence intervals for additional baseline demographic parameters (BMI, diabetes type, Hb...

Additional file 1: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Figure S1. ETDRS grid in place centered at the fovea. Note that ETDRS grid plotted (7.2 mm in diamet...

Additional file 3: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S2. Comparison of outcome measures between anatomic responders and non-responders at baseline,...

Additional file 4: Table S4. of Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

F. Ziemssen (3682612)
N. Feltgen (3682609)
FG. Holz (3682621)
R. Guthoff (3682618)
A. Ringwald (3682606)
T. Bertelmann (3682624)
A. Wiedon (3682615)
C. Korb (3682603)

January 2017

Table of confidence intervals for medical history parameters in the indication neovascular age-relat...

Additional file 1: Table S1. of Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study

Yule Xu (4393450)
Ao Rong (4393447)
Wei Xu (28953)
Yunli Niu (4393444)
Zhen Wang (72451)

August 2017

Main outcome measures of 12Â month follow-up. Excel table including the raw data of the changes in b...

Additional file 2: of Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis

Qiuying Chen (157606)
Bin Zhang (64682)
Yuhao Dong (2180608)
Xiaokai Mo (4096834)
Lu Zhang (50563)
Wenhui Huang (588369)
Hua Jiang (123031)
Jiejun Xia (3141261)
Shuixing Zhang (754970)

April 2018

The outcomes of meta-analysis in intravenous chemotherapy based on ICRB grading. (DOCX 280 kb

Additional file 2: of Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

Noemi Lois (6328916)
Evie Gardner (5576537)
Norman Waugh (371970)
Augusto Azuara-Blanco (6328919)
Hema Mistry (3325194)
Danny McAuley (6100556)
Nachiketa Acharya (6328922)
Tariq Aslam (5058305)
Clare Bailey (2694178)
Victor Chong (6328925)
Louise Downey (4989302)
Haralabos Eleftheriadis (6328928)
Samia Fatum (6328931)
Sheena George (4984052)
Faruque Ghanchi (6328934)
Markus Groppe (6328937)
Robin Hamilton (4720791)
Geeta Menon (748783)
Ahmed Saad (3476342)
Sobha Sivaprasad (318118)
Marianne Shiew (6328940)
David Steel (87365)
James Talks (6328943)
Catherine Adams (5576543)
Christina Campbell (5576546)
Matthew Mills (2418784)
Mike Clarke (9392)

February 2019

Roles and responsibilities of the Trial Steering Committee (TSC) and Data monitoring and Ethics Comm...

Additional file 1: of Cost-effectiveness of fluocinolone acetonide implant (ILUVIENÂŽ) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Michal Pochopien (6192851)
Annette Beiderbeck (6192857)
Phil McEwan (688067)
Richard Zur (6192860)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)

January 2019

Figure S1. Treatment strategies in the model â study and fellow eye. (DOCX 36 kb

Supplemental_Table_1 – Supplemental material for Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema

Robert M Carroll (6370166)
Yinxi Yu (1946899)
Brian L VanderBeek (6370169)

February 2019

Supplemental material, Supplemental_Table_1 for Predictive factors for patients receiving intravitre...

Additional file 6: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S5. Results of the linear regression model obtained using all predictors of the increase of BC...

Additional file 1: of Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant

Sibylle Winterhalter (3575630)
Gerrit vom Brocke (3575633)
Daniel Pilger (270591)
Annabelle Eckert (3575621)
Juliane Schlomberg (651164)
Anne RĂźbsam (3575642)
Matthias Klamann (3575636)
Enken Gundlach (847310)
Tina Dietrich-Ntoukas (3575639)
Antonia Joussen (3575627)

October 2016

a-c) waterfall plots of the ETDRS letter change 1 to 5Â months after DEX implantation compared to ba...

Additional file 1: of One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy

Hsin-Yu Weng (6701684)
Tzu-Lun Huang (6701687)
Pei-Yao Chang (6701690)
Jia-Kang Wang (6701693)

May 2019

The raw data of the study. âOne-year outcome of combination therapy with intravitreal aflibercept ...

Additional file 1: of Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis

Kristina Lundwall (5791676)
Stefan Jacobson (5791679)
Gun Jรถrneskog (5791685)
Jonas Spaak (4338955)

September 2018

(SearchCochrane): Data search Cochrane; Data search strategy for Cochrane reviews and Cochrane trial...

Additional file 2: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S1. Baseline values for BCVA, CRT and SFCT. Differences in BCVA, CRT and SFCT between endpoint...

Additional file 2: of Cost-effectiveness of fluocinolone acetonide implant (ILUVIENÂŽ) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Michal Pochopien (6192851)
Annette Beiderbeck (6192857)
Phil McEwan (688067)
Richard Zur (6192860)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)

January 2019

NMA SLR supplement Supplementary materials explaining the methods used in the systematic literature ...

Additional file 6: Table S6. of Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

F. Ziemssen (3682612)
N. Feltgen (3682609)
FG. Holz (3682621)
R. Guthoff (3682618)
A. Ringwald (3682606)
T. Bertelmann (3682624)
A. Wiedon (3682615)
C. Korb (3682603)

January 2017

Table of confidence intervals for additional baseline demographic parameters (BMI, diabetes type, Hb...

Additional file 1: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Figure S1. ETDRS grid in place centered at the fovea. Note that ETDRS grid plotted (7.2 mm in diamet...

Additional file 3: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S2. Comparison of outcome measures between anatomic responders and non-responders at baseline,...

Additional file 4: Table S4. of Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

F. Ziemssen (3682612)
N. Feltgen (3682609)
FG. Holz (3682621)
R. Guthoff (3682618)
A. Ringwald (3682606)
T. Bertelmann (3682624)
A. Wiedon (3682615)
C. Korb (3682603)

January 2017

Table of confidence intervals for medical history parameters in the indication neovascular age-relat...

Additional file 1: Table S1. of Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study

Yule Xu (4393450)
Ao Rong (4393447)
Wei Xu (28953)
Yunli Niu (4393444)
Zhen Wang (72451)

August 2017

Main outcome measures of 12Â month follow-up. Excel table including the raw data of the changes in b...

Additional file 2: of Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis

Qiuying Chen (157606)
Bin Zhang (64682)
Yuhao Dong (2180608)
Xiaokai Mo (4096834)
Lu Zhang (50563)
Wenhui Huang (588369)
Hua Jiang (123031)
Jiejun Xia (3141261)
Shuixing Zhang (754970)

April 2018

The outcomes of meta-analysis in intravenous chemotherapy based on ICRB grading. (DOCX 280 kb

Additional file 2: of Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

Noemi Lois (6328916)
Evie Gardner (5576537)
Norman Waugh (371970)
Augusto Azuara-Blanco (6328919)
Hema Mistry (3325194)
Danny McAuley (6100556)
Nachiketa Acharya (6328922)
Tariq Aslam (5058305)
Clare Bailey (2694178)
Victor Chong (6328925)
Louise Downey (4989302)
Haralabos Eleftheriadis (6328928)
Samia Fatum (6328931)
Sheena George (4984052)
Faruque Ghanchi (6328934)
Markus Groppe (6328937)
Robin Hamilton (4720791)
Geeta Menon (748783)
Ahmed Saad (3476342)
Sobha Sivaprasad (318118)
Marianne Shiew (6328940)
David Steel (87365)
James Talks (6328943)
Catherine Adams (5576543)
Christina Campbell (5576546)
Matthew Mills (2418784)
Mike Clarke (9392)

February 2019

Roles and responsibilities of the Trial Steering Committee (TSC) and Data monitoring and Ethics Comm...

Additional file 1: of Cost-effectiveness of fluocinolone acetonide implant (ILUVIENÂŽ) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Michal Pochopien (6192851)
Annette Beiderbeck (6192857)
Phil McEwan (688067)
Richard Zur (6192860)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)

January 2019

Figure S1. Treatment strategies in the model â study and fellow eye. (DOCX 36 kb

Supplemental_Table_1 – Supplemental material for Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema

Robert M Carroll (6370166)
Yinxi Yu (1946899)
Brian L VanderBeek (6370169)

February 2019

Supplemental material, Supplemental_Table_1 for Predictive factors for patients receiving intravitre...

Additional file 6: of Evaluation of markers of outcome in real-world treatment of diabetic macular edema

António Campos (5890568)
Elisa Campos (1889953)
Anália do Carmo (5890571)
Francisco Caramelo (4736646)
João Martins (5652628)
João Sousa (5877425)
António Ambrósio (5890574)
Rufino Silva (3843589)

October 2018

Table S5. Results of the linear regression model obtained using all predictors of the increase of BC...

Additional file 1: of Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant

Sibylle Winterhalter (3575630)
Gerrit vom Brocke (3575633)
Daniel Pilger (270591)
Annabelle Eckert (3575621)
Juliane Schlomberg (651164)
Anne RĂźbsam (3575642)
Matthias Klamann (3575636)
Enken Gundlach (847310)
Tina Dietrich-Ntoukas (3575639)
Antonia Joussen (3575627)

October 2016

a-c) waterfall plots of the ETDRS letter change 1 to 5Â months after DEX implantation compared to ba...

Additional file 1: of One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy

Hsin-Yu Weng (6701684)
Tzu-Lun Huang (6701687)
Pei-Yao Chang (6701690)
Jia-Kang Wang (6701693)

May 2019

The raw data of the study. âOne-year outcome of combination therapy with intravitreal aflibercept ...

Additional file 1: of Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis

Kristina Lundwall (5791676)
Stefan Jacobson (5791679)
Gun Jรถrneskog (5791685)
Jonas Spaak (4338955)

September 2018

(SearchCochrane): Data search Cochrane; Data search strategy for Cochrane reviews and Cochrane trial...

Additional file 2: of A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

Abstract

Extracted data

Additional file 2: of A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

Abstract

Extracted data

Related items

Related items